0.2834
1.14%
+0.0032
Handel nachbörslich:
.2897
0.0063
+2.22%
Qualigen Therapeutics Inc Aktie (QLGN) Neueste Nachrichten
Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
GlobeNewswire Inc.
Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting
GlobeNewswire Inc.
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga
Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
GlobeNewswire Inc.
Kapitalisierung:
|
Volumen (24h):